These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16118554)

  • 1. Single-session magnetic resonance coronary angiography and myocardial perfusion imaging using the new blood pool compound B-22956 (gadocoletic acid): initial experience in a porcine model of coronary artery disease.
    Zheng J; Li D; Maggioni F; Abendschein D; Simonetti O; Laub G; Finn JP; Gropler RJ; Cavagna FM
    Invest Radiol; 2005 Sep; 40(9):604-13. PubMed ID: 16118554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of coronary stenoses with contrast enhanced, three-dimensional free breathing coronary MR angiography using the gadolinium-based intravascular contrast agent gadocoletic acid (B-22956).
    Paetsch I; Jahnke C; Barkhausen J; Spuentrup E; Cavagna F; Schnackenburg B; Huber M; Stuber M; Fleck E; Nagel E
    J Cardiovasc Magn Reson; 2006; 8(3):509-16. PubMed ID: 16755840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla.
    Su MY; Yang KC; Wu CC; Wu YW; Yu HY; Tseng RY; Tseng WY
    J Cardiovasc Magn Reson; 2007; 9(4):633-44. PubMed ID: 17578718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement.
    Paetsch I; Huber ME; Bornstedt A; Schnackenburg B; Boesiger P; Stuber M; Fleck E; Cavagna F; Nagel E
    J Magn Reson Imaging; 2004 Aug; 20(2):288-93. PubMed ID: 15269955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of various parameters for determining an index of myocardial perfusion reserve in detecting coronary stenosis with cardiovascular magnetic resonance tomography].
    al-Saadi N; Gross M; Bornstedt A; Schnackenburg B; Klein C; Fleck E; Nagel E
    Z Kardiol; 2001 Nov; 90(11):824-34. PubMed ID: 11771450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of myocardial perfusion for detection of coronary artery stenoses by steady-state, free-precession magnetic resonance first-pass imaging.
    Merkle N; Wöhrle J; Grebe O; Nusser T; Kunze M; Kestler HA; Kochs M; Hombach V
    Heart; 2007 Nov; 93(11):1381-5. PubMed ID: 17488772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography.
    Plein S; Radjenovic A; Ridgway JP; Barmby D; Greenwood JP; Ball SG; Sivananthan MU
    Radiology; 2005 May; 235(2):423-30. PubMed ID: 15858084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease.
    Cury RC; Cattani CA; Gabure LA; Racy DJ; de Gois JM; Siebert U; Lima SS; Brady TJ
    Radiology; 2006 Jul; 240(1):39-45. PubMed ID: 16793971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated cardiac magnetic resonance imaging with coronary magnetic resonance angiography, stress-perfusion, and delayed-enhancement imaging for the detection of occult coronary artery disease in asymptomatic individuals.
    Song KD; Kim SM; Choe YH; Jung W; Lee SC; Chang SA; Choi YH; Sung J
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():77-89. PubMed ID: 25916321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
    Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of myocardial response in CMR perfusion imaging using Gd-BOPTA (Multihance).
    Gebker R; Paetsch I; Neuss M; Schnackenburg B; Bornstedt A; Jahnke C; Gomaa O; Fleck E; Nagel E
    J Cardiovasc Magn Reson; 2005; 7(3):565-72. PubMed ID: 15959969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary injection of contrast media maps the territory of the coronary artery: an MRI technique for assessing the effects of locally delivered angiogenic therapies.
    Carlsson M; Saeed M
    Acad Radiol; 2008 Nov; 15(11):1354-9. PubMed ID: 18995187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans.
    Wagner M; Wagner S; Schnorr J; Schellenberger E; Kivelitz D; Krug L; Dewey M; Laule M; Hamm B; Taupitz M
    J Magn Reson Imaging; 2011 Oct; 34(4):816-23. PubMed ID: 21769977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs.
    Dirksen MS; Lamb HJ; Kunz P; Robert P; Corot C; de Roos A
    Radiology; 2003 Jun; 227(3):802-8. PubMed ID: 12676975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: a comparison with coronary angiography and cardiac magnetic resonance.
    Arnold JR; Karamitsos TD; Pegg TJ; Francis JM; Olszewski R; Searle N; Senior R; Neubauer S; Becher H; Selvanayagam JB
    JACC Cardiovasc Imaging; 2010 Sep; 3(9):934-43. PubMed ID: 20846628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium.
    Taupitz M; Schnorr J; Wagner S; Abramjuk C; Pilgrimm H; Kivelitz D; Schink T; Hansel J; Laub G; Hünigen H; Hamm B
    Radiology; 2002 Jan; 222(1):120-6. PubMed ID: 11756715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions.
    Jahnke C; Gebker R; Manka R; Schnackenburg B; Fleck E; Paetsch I
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):375-84. PubMed ID: 20394899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease.
    Gebker R; Jahnke C; Paetsch I; Kelle S; Schnackenburg B; Fleck E; Nagel E
    Radiology; 2008 Apr; 247(1):57-63. PubMed ID: 18305188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gradient-echo and steady-state free precession for coronary artery magnetic resonance angiography using a gadolinium-based intravascular contrast agent.
    Deshpande VS; Cavagna F; Maggioni F; Schirf BE; Omary RA; Li D
    Invest Radiol; 2006 Mar; 41(3):292-8. PubMed ID: 16481912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.